Identification and expression of two forms of the human transforming growth factor‐β‐binding protein endoglin with distinct cytoplasmic regions
- 1 September 1993
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 23 (9), 2340-2345
- https://doi.org/10.1002/eji.1830230943
Abstract
Endoglin is an homodimeric membrane antigen with capacity to bind transforming growth factor-β (TGF-β) and whose expression is up-regulated on myeloid cells upon differentiation to macrophages. We have isolated full-length cDNA clones from a λgtl0 library, prepared from phorbol 12-myristate 13-acetate-differentiated HL60 cells by screening with an endoglin-specific cDNA probe from endothelial cells. Sequencing of the largest clone (3073 bp), revealed that the leader sequence contains 25 residues and that the 586 amino acids of the extracellular and transmembrane domains were identical to those described for endothelial endoglin. However, the cytoplasmic tail encoded by this cDNA clone contains only 14 amino acids as opposed to the 47 residues previously reported, suggesting the existence of two alternative endoglin variants. The expression of these isoforms was demonstrated by polymerase chain reaction analyses on endothelial cells, myelomonocytic cell lines HL-60 and U-937, and placenta. Independent cDN A constructs corresponding to both forms were transfected into mouse fibroblasts leading to the expression of two distinct endoglin molecules. Both forms were shown to bind TGF-β1 and, when overexpressed in transfected mouse fibroblasts, to form disulfide-linked homodimers, indicating that the cysteine residues present in the extracellular domain are responsible for the dimerization.Keywords
This publication has 24 references indexed in Scilit:
- Molecular cloning and characterization of the human and porcine transforming growth factor-β type III receptorsBiochemical and Biophysical Research Communications, 1992
- Endoglin: a 180-kD endothelial cell and macrophage restricted differentiation moleculeClinical and Experimental Immunology, 1992
- Regulated expression on human macrophages of endoglin, an Arg‐Gly‐Asp‐containing surface antigenEuropean Journal of Immunology, 1992
- Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinaseCell, 1992
- Novel activin receptors: Distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptorsCell, 1992
- Expression cloning and characterization of the TGF-β type III receptorCell, 1991
- Structure and expression of the membrane proteoglycan betaglycan, a component of the TGF-β receptor systemCell, 1991
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990
- Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain.The Journal of Experimental Medicine, 1986
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979